Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
811.00    3.00 (0.37%)
Bid:
810.00
Ask:
812.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Trading Statement

17 Dec 2008 07:00

RNS Number : 2691K
Savills PLC
17 December 2008
 



17 December 2008

SAVILLS PLC

("Savills" or "the Company")

Trading Update 

Savills, the international property adviser, publishes its trading update for the year ended 31 December 2008 prior to entering the close period before the announcement of full year results, which is scheduled for release on 11 March 2009.

Since our Interim Management Statement on 17 October 2008, our Transactional businesses world-wide have continued to operate in challenging markets. Whilst some deals are completing, we are not seeing the seasonal pick up in activity we have grown to expectMany pipeline transactions, which were at an advanced stage, have either been delayed or are not proceeding.

Our Consultancy businesses are continuing to trade well but are starting to see the effects of the challenging market conditions with a slowdown in new instructions.

The Property Management businesses continue to experience good demand for their services.

Fund Management is benefiting from its contracted revenue streams, but, given the current economic climate, fund raising during the year has been modest and transaction fees have been lower than planned.

Financial Services, which is predominately UK Mortgage broking, has seen market conditions deteriorate further. 

Overall, our main UK Residential, UK Commercial and Asian businesses are performing as expected during the last quarter of 2008. However, our businesses in Europe and the US and our mortgage broking business, which are all very heavily dependent on transactions, have experienced a significant fall off in expected 2008 volume

December is an important trading month and billing is still taking place. However, we now expect our underlying profit before tax for 2008 to be significantly below the current range of analyst forecasts.

In these challenging markets, our robust balance sheet and committed bank facilities until 2011 are a major strength. The Board will consider its dividend policy in light of the full year result for 2008 and trading in the early part of 2009.

A return to higher levels of transactional activity will depend on how quickly confidence returns to financial markets. The steps that we continue to take to reduce costs and our successful strategy of reducing dependence on transactional income will continue to serve us well in these uncertain times. 

For further information, contact:

Savills

020 7409 8844

Jeremy Helsby 

Mark Dearsley 

Danny O'Donnell

Tulchan

020 7353 4200

John Sunnucks

Paul Harris 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUGCWPUPRPUQ
Date   Source Headline
1st Feb 202411:00 amRNSTotal Voting Rights
22nd Jan 20249:11 amRNSBlock listing Interim Review
11th Jan 20244:02 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNSYear End Trading Update
2nd Jan 202412:33 pmRNSTotal Voting Rights
15th Dec 202310:00 amRNSAdditional Listing
14th Dec 202312:56 pmRNSDirector/PDMR Shareholding
13th Dec 202311:42 amRNSNon-Executive Director Appointment
13th Nov 20232:02 pmRNSSAVILLS APPOINTS NEW CEO OF SAVILLS NORTH AMERICA
13th Nov 202312:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20233:16 pmRNSForm 8.3 - OntheMarket PLC
1st Nov 202310:00 amRNSTotal Voting Rights
27th Oct 202310:00 amRNSAdditional Listing
12th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20238:50 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSAdditional Listing
12th Sep 20235:10 pmRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
18th Aug 20232:00 pmRNSAdditional Listing
15th Aug 20234:06 pmRNSBlock listing Interim Review
14th Aug 20232:05 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSChair Succession
10th Aug 20237:00 amRNSHalf-year Report
21st Jul 202310:00 amRNSBlock listing Interim Review
11th Jul 202312:50 pmRNSDirector/PDMR Shareholding
4th Jul 20239:20 amRNSTotal Voting Rights
13th Jun 20235:31 pmRNSDirector/PDMR Shareholding
1st Jun 202310:00 amRNSTotal Voting Rights
17th May 20234:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
11th May 20236:12 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20235:15 pmRNSDirector/PDMR Shareholding
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:15 pmRNSAnnual Report and AGM Notice
30th Mar 20237:47 amRNSAdditional Listing
16th Mar 20237:00 amRNSFinal Results
14th Mar 20235:07 pmRNSHolding(s) in Company
13th Mar 202311:06 amRNSDirector/PDMR Shareholding
1st Mar 202310:00 amRNSTotal Voting Rights
16th Feb 202311:17 amRNSBlock listing Interim Review
13th Feb 20234:32 pmRNSDirector/PDMR Shareholding
23rd Jan 202312:45 pmRNSBlock listing Interim Review
12th Jan 20234:10 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSYear End Trading Update
15th Dec 202211:59 amRNSNon-Executive Director Appointment
13th Dec 20221:20 pmRNSDirector/PDMR Shareholding
2nd Dec 202211:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.